These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33548873)

  • 1. Hepatic in vitro metabolism of peptides; Comparison of human liver S9, hepatocytes and Upcyte hepatocytes with cyclosporine A, leuprorelin, desmopressin and cetrorelix as model compounds.
    Jyrkäs J; Tolonen A
    J Pharm Biomed Anal; 2021 Mar; 196():113921. PubMed ID: 33548873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrahepatic in vitro metabolism of peptides; comparison of human kidney and intestinal S9 fraction, human plasma and proximal tubule cells, using cyclosporine A, leuprorelin, and cetrorelix as model compounds.
    Jyrkäs J; Lassila T; Tolonen A
    J Pharm Biomed Anal; 2023 Feb; 225():115219. PubMed ID: 36630767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of various in vitro model systems of the metabolism of synthetic doping peptides: Proteolytic enzymes, human blood serum, liver and kidney microsomes and liver S9 fraction.
    Zvereva I; Semenistaya E; Krotov G; Rodchenkov G
    J Proteomics; 2016 Oct; 149():85-97. PubMed ID: 27569051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro models for metabolic studies of small peptide hormones in sport drug testing.
    Esposito S; Deventer K; Geldof L; Van Eenoo P
    J Pept Sci; 2015 Jan; 21(1):1-9. PubMed ID: 25469748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of alcohol ethoxylates (AEs) in rat, hamster, and human hepatocytes and liver S9: a pilot study for metabolic stability, metabolic pathway, and metabolites identification in vitro and in silico.
    Shi Q; Moors S; Dawick J; Kavanagh L; Neely T; Tian Y; Dreeßen B; Carrillo JC; Hein H; Boogaard PJ
    Arch Toxicol; 2024 Aug; 98(8):2487-2539. PubMed ID: 38844554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NADPH-cytochrome P450 reductase expression and enzymatic activity in primary-like human hepatocytes and HepG2 cells for in vitro biotransformation studies.
    Schulz C; Kammerer S; Küpper JH
    Clin Hemorheol Microcirc; 2019; 73(1):249-260. PubMed ID: 31561354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of GSH-trapped reactive metabolites in human liver microsomes, S9 fraction, HepaRG-cells, and human hepatocytes.
    Lassila T; Rousu T; Mattila S; Chesné C; Pelkonen O; Turpeinen M; Tolonen A
    J Pharm Biomed Anal; 2015 Nov; 115():345-51. PubMed ID: 26263063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolite identification and profile of endosulfan sulfate in three human liver preparations using liquid chromatography-high resolution mass spectrometry.
    Lee HK; Kong TY; Choi WG; Kim JH; Shin Y; Lee HS; Lee YS; Kim JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1140():121996. PubMed ID: 32014661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised controlled trial comparing GnRH antagonist cetrorelix with GnRH agonist leuprorelin for endometrial thinning prior to transcervical resection of endometrium.
    Bhatia K; Doonan Y; Giannakou A; Bentick B
    BJOG; 2008 Sep; 115(10):1214-24. PubMed ID: 18715405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New psychoactive substances: Studies on the metabolism of XLR-11, AB-PINACA, FUB-PB-22, 4-methoxy-α-PVP, 25-I-NBOMe, and meclonazepam using human liver preparations in comparison to primary human hepatocytes, and human urine.
    Richter LHJ; Maurer HH; Meyer MR
    Toxicol Lett; 2017 Oct; 280():142-150. PubMed ID: 28782580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism and plasma protein binding of 16 straight- and branched-chain parabens in in vitro liver and skin models.
    Lester C; Hewitt NJ; Müller-Vieira U; Mayer M; Ellison C; Duplan H; Genies C; Jacques-Jamin C; Fabian E; Sorrell I; Lange D; Schepky A; Grégoire S
    Toxicol In Vitro; 2021 Apr; 72():105051. PubMed ID: 33188879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct comparison of UDP-glucuronosyltransferase and cytochrome P450 activities in human liver microsomes, plated and suspended primary human hepatocytes from five liver donors.
    den Braver-Sewradj SP; den Braver MW; Baze A; Decorde J; Fonsi M; Bachellier P; Vermeulen NPE; Commandeur JNM; Richert L; Vos JC
    Eur J Pharm Sci; 2017 Nov; 109():96-110. PubMed ID: 28778465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nonradioactive approach to investigate the metabolism of therapeutic peptides by tagging with 127i and using inductively-coupled plasma mass spectrometry analysis.
    Lim HK; Cao Y; Qiu X; Silva J; Evans DC
    Drug Metab Dispos; 2015 Jan; 43(1):17-26. PubMed ID: 25315343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of human liver and EpiSkin™ S9 subcellular fractions as a screening assays to compare the in vitro hepatic and dermal metabolism of 47 cosmetics-relevant chemicals.
    Eilstein J; Grégoire S; Fabre A; Arbey E; Géniès C; Duplan H; Rothe H; Ellison C; Cubberley R; Schepky A; Lange D; Klaric M; Hewitt NJ; Jacques-Jamin C
    J Appl Toxicol; 2020 Mar; 40(3):416-433. PubMed ID: 31912921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LC-high resolution-MS/MS for identification of 69 metabolites of the new psychoactive substance 1-(4-ethylphenyl-)-N-[(2-methoxyphenyl)methyl] propane-2-amine (4-EA-NBOMe) in rat urine and human liver S9 incubates and comparison of its screening power with further MS techniques.
    Caspar AT; Westphal F; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2018 Jan; 410(3):897-912. PubMed ID: 28762065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the in vitro metabolic stability and metabolites of the anticancer derivative riccardin D-N in human and mouse hepatic S9 fractions using HPLC-Q-LIT-MS.
    Gao Y; Liu R; Gautam N; Ma B; Xie Z; Sun B; Zheng H; Liu D; Lou H
    J Pharm Biomed Anal; 2019 Sep; 174():734-743. PubMed ID: 31299454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The formation of estrogen-like tamoxifen metabolites and their influence on enzyme activity and gene expression of ADME genes.
    Johänning J; Kröner P; Thomas M; Zanger UM; Nörenberg A; Eichelbaum M; Schwab M; Brauch H; Schroth W; Mürdter TE
    Arch Toxicol; 2018 Mar; 92(3):1099-1112. PubMed ID: 29285606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of okadaic acid by NADPH-dependent enzymes present in human or rat liver S9 fractions results in different toxic effects.
    Kolrep F; Rein K; Lampen A; Hessel-Pras S
    Toxicol In Vitro; 2017 Aug; 42():161-170. PubMed ID: 28414161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro metabolic products of RWJ-34130, an antiarrythmic agent, in rat liver preparations.
    Wu WN; McKown LA; Yorgey KA; Pritchard JF
    J Pharm Biomed Anal; 1999 Aug; 20(4):687-95. PubMed ID: 10704138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.